THE ADVI ANGLE

Resources and insights to help you keep up with policy and market trends in a transforming healthcare ecosystem

Showing Articles

Excitement, Anticipation, Questions Await as ASCO 2022 Begins

Will a new targeting therapy for HER2 breast cancer show promise for more patients? By Dr. Michael Kolodziej There is an old adage that “absence makes the heart grow fonder.” This holds particularly true for this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, which gets underway today in Chicago. As I mentioned in […]

Read more

ASCO 2022 is Back the Way it Should Be, in Person

By Dr. Michael Kolodziej On June 3, thousands of oncologists, oncology researchers and biopharmaceutical companies will convene at the McCormick Place Convention Center in Chicago for the American Society of Clinical Oncology (ASCO) Annual Meeting. After COVID-19 forced this industry premier event to be conducted virtually the past few years, there will be much shared […]

Read more

ADVI’s Lindsay Bealor Greenleaf spoke to AIS Health about the drug pricing provisions currently being considered in spending bill negotiations and how they would impact the payment & reimbursement of drugs.

ADVI’s Lindsay Bealor Greenleaf spoke to AIS Health about the drug pricing provisions currently being considered in spending bill negotiations and how they would impact the payment & reimbursement of drugs. Read more

Read more

ADVI Finds New CAR-T DRG 018 Used by 10 New Hospitals in FY 2021 and 11% Increase in Reimbursement

ADVI Finds New CAR-T DRG 018 Used by 10 New Hospitals in FY 2021 and 11% Increase in Reimbursement. DOWNLOAD THE FULL ANALYSIS HERE

Read more